Parental Awareness & Early Identification of Speech and Language delay in Toddlers
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2025
Project Lead
Authors
Mousa Alramadhan, Noura Almatroushi, Anwaar Mubarak, Jawad Alali, Sharifah Tumayhi, Aisha Alarfaj, Ghala Alsughayyir, Ahmad Al-Ali, Ali Alnajim, Hanadi Albatati
Project Status
completed
Project Type
Project